These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 17439065

  • 1. [Telomerase activity: a molecular marker for early diagnosis of bladder tumor].
    Calistri D, Sanchini A, Amadori D, Silvestrini R.
    Recenti Prog Med; 2007 Feb; 98(2):74-8. PubMed ID: 17439065
    [Abstract] [Full Text] [Related]

  • 2. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer.
    Dettlaff-Pokora A, Matuszewski M, Schlichtholz B.
    Cancer Lett; 2005 May 10; 222(1):83-8. PubMed ID: 15837544
    [Abstract] [Full Text] [Related]

  • 3. Telomerase and other novel approaches to bladder cancer detection.
    Bennett A.
    Clin Lab Sci; 2008 May 10; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
    [Abstract] [Full Text] [Related]

  • 4. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
    Siracusano S, Niccolini B, Knez R, Tiberio A, Benedetti E, Bonin S, Ciciliato S, Pappagallo GL, Belgrano E, Stanta G.
    Eur Urol; 2005 Mar 10; 47(3):327-33. PubMed ID: 15716196
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.
    Heine B, Hummel M, Müller M, Heicappell R, Miller K, Stein H.
    J Pathol; 1998 Jan 10; 184(1):71-6. PubMed ID: 9582530
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Significance of a simple assay of urine telomerase activity for the detection of bladder cancer].
    Iwabuchi I, Mori K, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Suzuki T, Ohyama C.
    Hinyokika Kiyo; 2010 Oct 10; 56(10):551-7. PubMed ID: 21063158
    [Abstract] [Full Text] [Related]

  • 9. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
    Bian W, Xu Z.
    Int J Urol; 2007 Feb 10; 14(2):108-11. PubMed ID: 17302565
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Telomerase: its clinical relevance in the diagnosis of bladder cancer.
    Müller M.
    Oncogene; 2002 Jan 21; 21(4):650-5. PubMed ID: 11850792
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Telomerase activity as marker of superficial tumor of the bladder].
    Arias Fúnez F, Fernández Fernández E, Escudero Barrilero A, Moyano Jato A, Caso Peláez E.
    Arch Esp Urol; 2000 Apr 21; 53(3):231-6. PubMed ID: 10851728
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer.
    Varella-Garcia M, Akduman B, Sunpaweravong P, Di Maria MV, Crawford ED.
    Urol Oncol; 2004 Apr 21; 22(1):16-9. PubMed ID: 14969798
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.